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Purpose/Objective: This study is to investigate the body 
contour changes and tumor regression in intensity modulated 
radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC) 
after 1-month of treatment and to identify factors associated 
with body contour changes. 
Materials and Methods: Thirty-eight newly diagnosed NPC 
patients were enrolled in this study and were treated with 
IMRT; computer-assisted tomography (CT) of head and neck 
for IMRT planning were performed twice, the 1st CT at one 
week before radiotherapy (Plan 1) and the 2nd CT at 22 
radiation treatments (Plan 2). Same physician outlined all 
target volumes and organs at risk. The physical objective and 
dose constraints were optimized with same criteria. Principle 
component analysis and clustering were used for body 
contour changes. We tried to identify variables associated 
with body contour changes before and after treatments. 
Results: Patient weight decreased remarkably after 1-month 
of radiotherapy. The average weight decreased by 3.0% 
(2.3kg, range 1.5-3.2kg). Comparing Plan 1 to Plan 2, the 
parotid gland volume was significantly reduced by 15.7% 
(10.8cc, ranged from 7.5-14.2cc); the submandibular gland 
volume by 15.8% (3.4cc, ranged from 2.14-4.65cc); GTV by 
15.5% (3.8cc, ranged from 2.4-5.3cc); and GTV-LN by 41.8% 
(15.1cc, ranged from 8.7-21.6cc). The separation distance in 
each slice of head and neck CT images reduced by average of 
0.32-0.89 cm (1.9%-6.0%), especially at the transverse 
diameter in the level of 3rd cervical spine (0.9cm). The GTV 
volume on average shrank 2.23cc and 6.91 cc as comparing 
T1-3 with T4 disease (p = 0.0013); The GTV-LN volume shrank 
on average 8.59 cc, 38.93 cc (p = 0.0208) as comparing N1-2 
with N3 disease. The transverse diameter changes of head 
and neck contours were correlated significantly with N stage 
and body weight loss. 
Conclusions: For NPC patients treated with IMRT, weight 
loss, volume reduction of salivary gland and body contour 
changes are common. The salivary glands on average reduced 
volume by 16% and GTV-LN by 42% after one-month 
treatment. The most significant factor associated with body 
contour changes is weight loss. We recommend repeat 
simulation after one-month of radiotherapy in order to 
reduce the dose to the normal organs and avoid missing 
treatment targets. 
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Purpose/Objective: To retrospectively assess the loco-
regional disease control in head-and-neck cancer (HNC) 
patients treated with Intensity Modulated Radiation Therapy 
(IMRT) and estimate the role of treatment plan dosimetry as 
a predictor for loco-regional control (LC). 
Materials and Methods: Between February 2012 and February 
2014, 30 consecutive patients with HNC were treated with 
Simultaneous Integrated Boost (SIB) IMRT. Their demographic 
and clinical variables, such as age at the time of diagnosis, 
gender, T and N stage and chemotherapy data were collected 
and analyzed. Planning CT images of all patients with loco-
regional failures were retrospectively reviewed and 
dosimetric data of the treatment plans investigated, seeking 
for a possible correlation between an eventual loco-regional 
disease relapse and the dose delivered to the area where the 
relapse occurred. Dose-Volume-Histograms (DVH) were used 
to extract D95%, D98% and Dmean values. Because DVH does not 
provide spatial information about hot and cold spots, 
Equivalent Uniform Dose (EUD) was considered too. As the 
dose varied among patients, for analysis we used values of 
D95%, D98%, Dmean and EUD normalized to the prescribed dose. 
Correlation of the available variables with LC was assessed by 
a logistic regression test and a p value of < 0.05 was 
considered significant. 
Results: After a median follow-up of 12 months (range: 1-28 
months), 8 (26%) patients presented loco-regional relapse and 
22 (64%) were free of disease. During this time, 3 (10%) 
patients died from the disease; all of them were tongue 
cancer cases. 
Table 1. Patient and tumor characteristics (n=30). 
 
 
Significantly improved LC of the disease was associated with 
nasopharyngeal diagnosis (p=0.0004), early stages (T1, 
p=0.0454; N0, p=0.0024), and the use of concomitant 
chemotherapy (p=0.0028).  
Treatment plans evaluation showed that all loco-regional 
relapses occurred within the 95% isodose line inside the 
Planning-Target-Volume (PTV) of the primary disease. 
Dosimetric parameters analysis showed a weak correlation 
